SCHEMBL6710182

SCHEMBL6710182

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4cccc5ccccc45)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
PARP14 Q460N5 1/20 0.40
KMT2A Q03164 6/20 0.38
MEN1 O00255 5/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
PTGER4 P35408 1/20 0.38
GLA P06280 1/20 0.38
MAPT P10636 1/20 0.38
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
POLB P06746 2/20 0.37
MAPK8 P45983 3/20 0.36
MAPK10 P53779 3/20 0.36
PLA2G7 Q13093 2/20 0.36
MAPK9 P45984 2/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707901 0.92 PARP14 (0.40) ALDH1A1PARP14MAPK8PLA2G7MAPK9
SCHEMBL6708561 0.92 NSD2 (0.39) ALDH1A1PARP14KMT2AMEN1HPGD
SCHEMBL6709308 0.91 TP53 (0.41) ALDH1A1KMT2AMEN1KDM4ELMNA
SCHEMBL6709207 0.90 PARP14 (0.43) ALDH1A1PARP14KDM4ELMNAPLA2G7
SCHEMBL6707743 0.90 PARP14 (0.37) ALDH1A1PARP14SMN1; SMN2MAPTMAPK8
SCHEMBL6711745 0.90 PLA2G7 (0.38) ALDH1A1PARP14KMT2AMEN1SMN1; SMN2
SCHEMBL6712548 0.89 KMT2A (0.48) ALDH1A1KMT2AMEN1HPGDKDM4E
SCHEMBL6707627 0.89 KMT2A (0.46) ALDH1A1PARP14KMT2AMEN1HPGD
SCHEMBL6710454 0.88 PARP14 (0.41) PARP14KMT2AMEN1LMNAMAPT
SCHEMBL6709031 0.88 PLA2G7 (0.37) ALDH1A1PARP14KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885PARP14 2597/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.